The percentage of a drug company’s sales can be shown over the course of four years, 2002 to 2006, and their distribution across three regions, namely America, Asia and Europe, is highlighted.
The overall trend suggests a rise in the share of sales in Asia with a respective decline in sales in America over the years. The drop from 41% to 30% shows a continuous reduction in sales of the company’s products over time. A 15% increase in Asia suggests a rise in demand and consequent supply, which added to the revenue of the company.
Europe’s share remained the most consistent, with occasional increases and decreases. Its share almost always remained a third of the overall sales of the company.
The trend of shares over the five years can easily be identified through the diagram with evident increases, decreases and consistent shares. The company can use this data effectively to predict a pattern for the upcoming years and focus its marketing and sales strategies in regions where it is necessary for growth.
